Steven Robert Pacelli

CIK 1359098 · EVP Managing Director Dexcom V · last filed 2023-11-27

Steven Robert Pacelli is an EVP Managing Director Dexcom V who has filed 176 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for DXCM, was dated Apr 23, 2024. Across all open-market trades the lifetime net is −$78.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.4M across reported positions. 15 Form 144 notices of planned sales are also on file; the latest, for DXCM on Apr 23, 2024, lists the filer as an officer. 9 sales listed on those notices, worth $5.5M in all, have no matching Form 4.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$10.43M
Companies
2
Total Filings
176
Lifetime Open-Market Net
-$78.36M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

DXCM price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
5555 OBERLIN DRIVE
SAN DIEGO, CA 92121
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DXCM EVP Managing Director Dexcom V 124,775 $83.58 $10.43M -$78.36M 160 2023-11-27
ProSomnus, Inc. (OSAAW) Delisted Director — $0.02 — $0 1 2023-02-02

Recent Filings

176 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2024-04-23 DXCM Notice (144)
Officer · Planned Apr 23, 2024 · 10b5-1 plan
No sale on file
−500 -$65.7K EDGAR
2024-03-22 DXCM Notice (144)
Officer · Planned Mar 22, 2024 · 10b5-1 plan
Sold: listed on the Apr 23, 2024 notice
−500 -$66.7K EDGAR
2024-03-07 DXCM Notice (144)
Officer · Planned Mar 7, 2024 · 10b5-1 plan
Sold: listed on the Mar 22, 2024 notice
−640 -$86.8K EDGAR
2024-03-06 DXCM Notice (144)
Officer · Planned Mar 6, 2024 · 10b5-1 plan
Sold: listed on the Mar 7, 2024 notice
−4,360 -$565.5K EDGAR
2024-02-26 DXCM Notice (144)
Officer · Planned Feb 26, 2024 · 10b5-1 plan
Sold: listed on the Mar 6, 2024 notice
−4,500 -$523.6K EDGAR
2023-11-27 DXCM Sell (S) −411 -$45.5K EDGAR
2023-11-24 DXCM Notice (144)
Officer · Planned Nov 24, 2023 · 10b5-1 plan
Sold: Form 4 filed Nov 27, 2023
−411 -$45.5K EDGAR
2023-10-23 DXCM Notice (144)
Officer · Planned Oct 23, 2023 · 10b5-1 plan
Sold: Form 4 filed Oct 23, 2023
−411 -$35.2K EDGAR
2023-10-23 DXCM Sell (S) −411 -$35.2K EDGAR
2023-09-22 DXCM Notice (144)
Officer · Planned Sep 22, 2023 · 10b5-1 plan
Sold: Form 4 filed Sep 22, 2023
−411 -$36.3K EDGAR
Showing 1–10 of 176
Page 1 of 18
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).

Sales Reported Only on Form 144

9 sales · $5.55M
Each Form 144 lists the seller's sales of the company's stock in the 3 months before it. These are the sales on this filer's notices that no Form 4 on file shows, which is the usual case once someone is no longer an officer or director, or for an affiliate who never files Form 4s. Each sale is listed once, with the first notice that reported it.
Sold Symbol Shares Proceeds Avg Price Listed On
2024-03-22 DXCM 500 $66.7K $133.41 2024-04-23
2024-03-12 DXCM 10,180 $1.37M $134.41 2024-03-22
2024-03-07 DXCM 640 $86.8K $135.60 2024-03-22
2024-03-06 DXCM 2,500 $320.0K $128.00 2024-03-07
2024-03-06 DXCM 1,860 $245.5K $132.00 2024-03-07
2024-02-26 DXCM 4,500 $523.6K $116.35 2024-03-06
2024-01-16 DXCM 2,736 $338.3K $123.63 2024-02-26
2023-03-10 DXCM 11,669 $1.30M $111.40 2023-05-23
2023-03-10 DXCM 11,669 $1.30M $111.40 2023-04-24